OCELLOS
DEAD

Serial Number

98304980

Owner

TrakCel Limited

Attorney

Bradley M. Stohry

Filing Date

Dec 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

OCELLOS Trademark

Serial Number: 98304980

OCELLOS is a trademark filed by TrakCel Limited on December 8, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

TrakCel Limited (3 trademarks)

10-11 Raleigh Walk,

Entity Type: 99

Trademark Details

Filing Date

December 8, 2023

Registration Date

Not Registered

Published for Opposition

January 7, 2025

Goods & Services

Downloadable software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Downloadable software for use in managing data for clinical trials; Downloadable software for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Downloadable software for use in drug therapy development; Downloadable software for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Downloadable software for the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Downloadable software for use in cell and gene therapy orchestration; Downloadable software for use in inventory management for scheduling and planning pharmaceutical resources; Downloadable software for use in control and tracking of cell and gene therapy products

Arranging and conducting of training courses in the field of cell and gene therapy; Arranging and conducting of training workshops in the field of operation and development of software systems; Arranging and conducting of training workshops in the field of cell and gene therapy; Training services in the field of cell and gene therapy

Platform as a service (PAAS) featuring computer software platforms for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Platform as a service (PAAS) featuring computer software platforms for use in managing data for clinical trials; Platform as a service (PAAS) featuring computer software platforms for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Platform as a service (PAAS) featuring computer software platforms for use in drug therapy development; Platform as a service (PAAS) featuring computer software platforms for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Platform as a service (PAAS) featuring computer software platforms for use in the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Platform as a service (PAAS) featuring computer software platforms for use in cell and gene therapy orchestration; Platform as a service (PAAS) featuring computer software platforms for use in inventory management for scheduling and planning pharmaceutical resources; Platform as a service (PAAS) featuring computer software platforms for use in control and tracking of cell and gene therapy products; Software as a service (SAAS) services featuring software platforms for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Software as a service (SAAS) services featuring software for use in managing data for clinical trials; Software as a service (SAAS) services featuring software for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Software as a service (SAAS) services featuring software for use in drug therapy development; Software as a service (SAAS) services featuring software for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Software as a service (SAAS) services featuring software for use in the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Software as a service (SAAS) services featuring software for use in cell and gene therapy orchestration; Software as a service (SAAS) services featuring software for use in pharmacy inventory management for scheduling and planning pharmaceutical resources; Software as a service (SAAS) services featuring software for use in control and tracking of cell and gene therapy products; Providing temporary use of non-downloadable cloud-based software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Providing temporary use of non-downloadable cloud-based software for use in managing data for clinical trials; Providing temporary use of non-downloadable cloud-based software for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Providing temporary use of non-downloadable cloud-based software for use in drug therapy development; Providing temporary use of non-downloadable cloud-based software for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Providing temporary use of non-downloadable cloud-based software for use in the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Providing temporary use of non-downloadable cloud-based software for use in cell and gene therapy orchestration; Providing temporary use of non-downloadable cloud-based software for use in pharmacy inventory management for scheduling and planning pharmaceutical resources; Providing temporary use of non-downloadable cloud-based software for use in control and tracking of cell and gene therapy products

Licensing of intellectual property in the field of cell and gene therapy; Software licensing; Granting of software licences

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 6, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 6, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 1 GRANTED
Sep 4, 2025 EX1G
SOU EXTENSION 1 FILED
Sep 4, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 4, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 10, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 10, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 17, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 9, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2024 NWOS
NEW APPLICATION ENTERED
Dec 12, 2023 NWAP